Pharma and Patient USA

Topics

• Patient-centric through diversity
• The new infrastructure of Patient Centricity
• Embed equity into clinical trial protocols and achieve inclusive patient journeys
• New players have entered the game
• Pharma’s "one foot in the grave" approach to digital patient engagement
• Use behavior analysis and real patient perspectives to provide genuine clinical value
• Diversifying commercial’s place in the new patient-centric equation